Last edition
News about "essential thrombocythemia drug"
US FDA Approves Treatment for Essential Thrombocythemia
The US Food and Drug Administration (FDA) approves Besremi (ropeginterferon alfa-2b-njft) for adults with essential thrombocythemia, with a recommended starting dose of 250 mcg.
Essential Thrombocythemia Drug | 02/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members